微細藻類市場は、予測期間中に6.93％の堅調なCAGRを記録すると予想されます。食品に栄養上の利点を付加する海藻の能力によって、海藻の需要は食品および飲料業界から世界中に拡大しています。たとえば、海藻はアジア諸国で以前からかなり消費されていました。それは、アジア系の人々が米国、カナダ、フランスなどのさまざまな国に広がっていることが原因です。
大型藻類は、食品に新たに添加されたり、健康食品を作るための食品成分として使用されたりします。さらに、食品の厚みと強度を高めるために、海藻から生成されたハイドロコロイドがいくつか使用されています。同様に、ゲルのフレーム化や水溶媒フィルムとしての使用など、いくつかの異なる用途があります。アルギン酸塩、カラギーナン、寒天は、本格的なgreen growth removesとして最も広く使用されています。
目次
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1.1 GLOBAL MICROALGAE MARKET, BY TYPE
1.1.2 GLOBAL MICROALGAE MARKET, BY FORM
1.1.3 GLOBAL MICROALGAE MARKET, BY SOURCE
1.1.4 GLOBAL MICROALGAE MARKET, BY APPLICATION
1.1.5 GLOBAL MICROALGAE MARKET, BY DISTRIBUTION CHANNEL
1.1.6 GLOBAL MICROALGAE MARKET, BY REGION
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 SCOPE OF THE STUDY
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 TOP DOWN & BOTTOM-UP APPROACH
3.6 FORECAST MODEL
3.7 LIST OF ASSUMPTIONS
4 MARKET DYNAMICS
4.1 DRIVERS
4.1.1 INCREASING CONSUMPTION OF PLANT-BASED PRODUCTS AND ADOPTION OF COMMERCIAL SEAWEED AS HYDROCOLLOIDS
4.1.2 INCREASED APPLICATION AREAS
4.1.3 DRIVER IMPACT ANALYSIS
4.2 RESTRAINTS
4.2.1 HIGH COST OF SEAWEED CULTIVATION AND STRINGENT REGULATIONS ON MICROALGAE PRODUCTION AND CONSUMPTION OF FOOD
4.2.2 RESTRAINT IMPACT ANALYSIS
4.3 OPPORTUNITIES
4.3.1 EXPANSION OF AQUACULTURE INDUSTRY AND INCREASING APPLICATION OF SPIRULINA MICROALGAE
4.4 CHALLENGES
5 MARKET FACTOR ANALYSIS
5.1 VALUE/SUPPLY CHAIN ANALYSIS
5.1.1 RAW MATERIALS
5.1.2 MANUFACTURING PROCESS
5.1.3 DISTRIBUTION
5.1.4 END USER
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROALGAE MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON PRODUCTION
5.3.3 IMPACT ON CONSUMER BUYING BEHAVIOR
5.3.4 IMPACT ON STORE-BASED VS ONLINE SALES
6 GLOBAL MICROALGAE MARKET, BY TYPE
6.1 OVERVIEW
6.2 DUNALIELLA SALINA
6.3 CHLORELLA
6.4 SPIRULINA
6.5 HAEMATOCOCCUS SPP
6.6 NANNOCHLOROPSIS
6.7 OTHERS
7 GLOBAL MICROALGAE MARKET, BY SOURCE
7.1 OVERVIEW
7.2 MARINE WATER
7.3 FRESH WATER
8 GLOBAL MICROALGAE MARKET, BY SOURCE FORM
8.1 OVERVIEW
8.2 DRY/POWDER
8.3 LIQUID
9 GLOBAL MICROALGAE MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 FOOD & BEVERAGES
9.3 PHARMACEUTICALS
9.4 COSMETICS & BEAUTY CARE PRODUCTS
9.5 ANIMAL FEED
9.6 BIO-FUEL
9.7 OTHERS
10 GLOBAL MICROALGAE MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 B2B
10.3 B2C
11 GLOBAL MICROALGAE, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 ITALY
11.3.4 SPAIN
11.3.5 UK
11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 JAPAN
11.4.3 INDIA
11.4.4 AUSTRALIA & NEW ZEALAND
11.4.5 REST OF ASIA PACIFIC
11.5 REST OF THE WORLD
11.5.1 SOUTH AMERICA
11.5.2 MIDDLE EAST
11.5.3 AFRICA
12 COMPETITIVE LANDSCAPE
12.1 COMPETITIVE OVERVIEW
12.2 MAJOR GROWTH STRATEGY IN THE GLOBAL MICROALGAE MARKET
12.3 COMPETITIVE BENCHMARKING
13 COMPANY PROFILES
13.1 ALGENOL BIOTECH
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 PRODUCTS OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 CELLANA, INC.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 PRODUCTS OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 CYANOTECH CORPORATION
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 PRODUCTS OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 SWOT ANALYSIS
13.3.6 KEY STRATEGIES
13.4 DIC CORPORATION
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 PRODUCTS OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 SWOT ANALYSIS
13.4.6 KEY STRATEGIES
13.5 EID PARRY.
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 PRODUCTS OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 SWOT ANALYSIS
13.5.6 KEY STRATEGIES
13.6 FUQING KING DNARMSA SPIRULINA CO., LTD.
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 PRODUCTS OFFERED
13.6.4 KEY DEVELOPMENTS
13.7 KENT BIOENERGY
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 PRODUCTS OFFERED
13.7.4 KEY DEVELOPMENTS
13.8 AUSTRALIAN SPIRULINA
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL OVERVIEW
13.8.3 PRODUCTS OFFERED
13.8.4 KEY DEVELOPMENTS
13.9 ASTAREAL AB.
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 PRODUCTS OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 KEY STRATEGIES
